Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Newly Profitable Medivation Riding High On Drug Sales
Investors.com
Saturday, November 29, 2014 - 10:28am
tags:
Medivation
Gilead Sciences: New Prescriptions for Hepatitis C Drugs Slow
Barron's
Saturday, November 29, 2014 - 10:27am
tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi
Pfizer deal probably 'would have fallen apart': AZ CEO
CNBC
Saturday, November 29, 2014 - 10:25am
tags:
Pfizer, AstraZeneca, M&A, Pascal Soriot, Pharma CEOs
FDA rejects Avanir's migraine drug-device
Yahoo/Reuters
Wednesday, November 26, 2014 - 11:33pm
tags:
FDA, Avanir, migraines, AVP-825
Ebola vaccine from Glaxo passes early safety test
Yahoo/Reuters
Wednesday, November 26, 2014 - 11:32pm
tags:
GSK, vaccines, ebola virus
Medtronic gets U.S. antitrust OK to buy Covidien with divestiture
Yahoo/Reuters
Wednesday, November 26, 2014 - 4:50pm
tags:
Medtronic, Covidien, M&A, FTC, devices
Hologic Produces the First FDA-Approved 3D Mammography Platform
Yahoo/GuruFocus
Wednesday, November 26, 2014 - 4:48pm
tags:
Hologic, FDA, 3-D mammograms, devices
Will Insulin Pricing Be MannKind Corporation's Downfall?
Motley Fool
Wednesday, November 26, 2014 - 12:11pm
tags:
MannKind, diabetes, insulin, inhaled insulin, Afrezza, drug pricing
FDA declines to approve Bristol-Myers hepatitis drug
Yahoo/Reuters
Wednesday, November 26, 2014 - 12:08pm
tags:
hepatitis C, Bristol-Myers Squibb, FDA, daclatasvir
Vivus awarded two patents for Qsymia
Seeking Alpha
Wednesday, November 26, 2014 - 12:05pm
tags:
Vivus, Qsymia, patents
Valeant adds to dermatology portfolio
Medical Marketing and Media
Wednesday, November 26, 2014 - 12:02pm
tags:
dermatology, Valeant Pharmaceuticals, FDA, Onexton, acne
Ipsen on a hiring binge in U.S. to prep for new Somatuline marketing push
Fierce Pharma Marketing
Wednesday, November 26, 2014 - 11:50am
tags:
Ipsen, Somatuline, hirings, drug launches
Who are the stars of personalized medicine? Roche, Novartis and J&J
Fierce Pharma Marketing
Wednesday, November 26, 2014 - 11:43am
tags:
personalized medicine, Roche, Novartis, JNJ
Amgen, AstraZeneca's brodalumab beats J&J's Stelara in 2nd PhIII psoriasis showdown
Fierce Biotech
Wednesday, November 26, 2014 - 11:38am
tags:
Amgen, AstraZeneca, brodalumab, JNJ, Stelara, psoriasis
Ackman's Pershing Square still holds 26.6 million Allergan shares
Yahoo/Reuters
Wednesday, November 26, 2014 - 11:35am
tags:
Bill Ackman, Allergan, M&A, Valeant Pharmaceuticals, Actavis
Should Drug Makers be Required to Take FDA Advice on Pivotal Trials?
WSJ Pharmalot
Wednesday, November 26, 2014 - 11:32am
tags:
FDA, clinical trials
Back for more: Will Pfizer top its AstraZeneca bid?
CNBC
Wednesday, November 26, 2014 - 10:07am
tags:
Pfizer, AstraZeneca, M&A
J&J hopes third time is the charm for antitumor agent Yondelis
Fierce Biotech
Tuesday, November 25, 2014 - 3:53pm
tags:
JNJ, Yondelis, ovarian cancer
Once-weekly Lilly diabetes drug wins EU approval
Yahoo/Reuters
Tuesday, November 25, 2014 - 3:19pm
tags:
Eli Lilly, diabetes, Europe, Trulicity
Covidien, Medtronic Shareholders Poised for January Vote
Yahoo/TheStreet
Tuesday, November 25, 2014 - 1:46pm
tags:
Covidien, Medtronic, M&A, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.